PGT NEXT

Detecting genetic abnormalities in embryos:

PGT helps identify abnormalities in chromosome number (PGT-A) or specific gene mutations (PGT-M), thereby reducing the risk of transmitting genetic diseases to the next generation.

Increasing IVF success rate:

Selecting healthy embryos with normal genomes helps improve implantation rate, increase the chance of pregnancy and reduce the risk of miscarriage.

Supporting optimal embryo selection:

Ensuring that only embryos without genetic diseases or genetic abnormalities are transferred to the uterus, contributing to increasing the chance of having a healthy child.

Illumina's next-generation sequencing technology (NGS) with >99% accuracy on target markers and specialized bioinformatics software —> Technology standard for PGT testing, increasing the accuracy and sensitivity of the test.